Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

PURPOSE: We presented retrospective analysis of up to five polymorphisms in TS, MTHFR and ERCC1 genes as molecular predictive markers for homogeneous Caucasian, non-squamous NSCLC patients treated with pemetrexed and platinum front-line chemotherapy. METHODS: The following polymorphisms in DNA isola...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Paweł, Kucharczyk, Tomasz, Kowalski, Dariusz M., Powrózek, Tomasz, Ramlau, Rodryg, Kalinka-Warzocha, Ewa, Winiarczyk, Kinga, Knetki-Wróblewska, Magdalena, Wojas-Krawczyk, Kamila, Kałakucka, Katarzyna, Dyszkiewicz, Wojciech, Krzakowski, Maciej, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228108/
https://www.ncbi.nlm.nih.gov/pubmed/25028118
http://dx.doi.org/10.1007/s00432-014-1756-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228108/
https://www.ncbi.nlm.nih.gov/pubmed/25028118
http://dx.doi.org/10.1007/s00432-014-1756-6

Ejemplares similares